Rocket Lab Forecasts Thursday EPS Loss Narrowed to $0.09, $178M Revenue
Rocket Lab shares slipped 1.3% Monday to $69.94 as investors position for Thursday’s earnings, with EPS expected to narrow losses to $0.09 and revenue to near $178.1 million. The stock climbed 7% over the past week on heightened defense demand and Cassowary Vex hypersonic test momentum after NASA Mars-funding cut.
1. Recent Stock Movement
Rocket Lab shares dropped 1.37% Monday to $69.94, trading 8.2% below its 20-day and 7.5% below its 50-day moving averages but remaining 7.5% above its 100-day and 35.1% above its 200-day averages. Over the past 12 months, shares have surged 210.6%, with RSI at 46.4 and MACD indicating slight bearish pressure.
2. Defense Projects and NASA Funding Impact
The stock climbed 7% over the trailing week as Rocket Lab conducted its fourth Cassowary Vex hypersonic test under the HASTE program for the Defense Innovation Unit, aiming to reduce test costs and increase launch cadence. Congressional withholding of NASA’s 2031 Mars sample-return mission funds has prompted a reassessment of Rocket Lab’s deep-space growth outlook.
3. Upcoming Earnings Expectations
Rocket Lab is set to report earnings Thursday after the close, with analysts forecasting an EPS loss narrowing to $0.09 from $0.10 previously and revenue rising to $178.07 million from $132.39 million in the prior quarter.
4. Analyst Ratings and Price Targets
Analysts maintain an average Buy rating with a $64.00 price target. Goldman Sachs, Bank of America, and Morgan Stanley have recently adjusted their targets to $69.00, $120.00, and $105.00 respectively, reflecting varied optimism about near-term growth drivers.